NovaQuest Capital Management
Latest statistics and disclosures from NovaQuest Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Myovant Sciences, RVNC, and represent 100.00% of NovaQuest Capital Management's stock portfolio.
- Reduced shares in these 1 stock: RVNC (-$9.6M).
- NovaQuest Capital Management was a net seller of stock by $-9.6M.
- NovaQuest Capital Management has $54M in assets under management (AUM), dropping by -37.12%.
- Central Index Key (CIK): 0001729264
Tip: Access up to 7 years of quarterly data
Positions held by NovaQuest Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for NovaQuest Capital Management
NovaQuest Capital Management holds 2 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Myovant Sciences | 90.0 | $49M | 3.5M | 14.05 |
|
|
| Revance Therapeutics (RVNC) | 10.0 | $5.4M | -63% | 216k | 25.14 |
|
Past Filings by NovaQuest Capital Management
SEC 13F filings are viewable for NovaQuest Capital Management going back to 2017
- NovaQuest Capital Management 2020 Q3 filed Nov. 13, 2020
- NovaQuest Capital Management 2020 Q2 filed July 24, 2020
- NovaQuest Capital Management 2020 Q1 filed April 24, 2020
- NovaQuest Capital Management 2019 Q4 filed Jan. 24, 2020
- NovaQuest Capital Management 2019 Q3 filed Oct. 25, 2019
- NovaQuest Capital Management 2019 Q2 filed July 29, 2019
- NovaQuest Capital Management 2019 Q1 filed May 8, 2019
- NovaQuest Capital Management 2018 Q4 filed Feb. 12, 2019
- NovaQuest Capital Management 2018 Q3 filed Nov. 7, 2018
- NovaQuest Capital Management 2018 Q2 filed Aug. 1, 2018
- NovaQuest Capital Management 2018 Q1 filed April 24, 2018
- NovaQuest Capital Management 2017 Q4 filed Feb. 13, 2018